Crossmark

The Therapeutic Efficacy of MS473, a Fully Human Single-Chain Variable Fragment Targeting Staphylococcus aureus Toxic Shock Syndrome Toxin-1, in a D-Galactosamine-Sensitized Mouse Model of Lethal Shock

Crossref DOI link: https://doi.org/10.1186/s12866-025-03825-8

Published Online: 2025-02-26

Update policy: https://doi.org/10.1007/springer_crossmark_policy

Authors

Rahimi-Jamnani, Fatemeh

Moradi, Hamid Reza

Fateh, Abolfazl

Azizi, Masoumeh

Nazari, Farzaneh

Soezi, Mahdieh

Siadat, Seyed Davar
License Information

Text and Data Mining valid from 2025-02-26

Version of Record valid from 2025-02-26
More Information

Article History

Received: 21 August 2024

Accepted: 13 February 2025

First Online: 26 February 2025

Declarations

:

: Animal experiments were conducted in accordance with ARRIVE guidelines () and approved by the Animal Care and Use Committees of the Pasteur Institute of Iran (IR.PII.REC.1398.028). All methods were performed in accordance with relevant guidelines and regulations.

: Not applicable.

: Not applicable.

: The authors declare no competing interests.

Document is current

Any future updates will be listed below